JW Life Science

JW Life Science Dividend Coverage

The Dividend Coverage Ratio of JW Life Science (234080.KS) as of Oct 21, 2026 is 5.68. In the previous year, Dividend Coverage Ratio was 3.64 — a change of 56.29% (higher).

Dividend Coverage

5.68

YoY

56.29%

Last updated:

Dividend Coverage Ratio of JW Life Science is 2024 5.68 . Dividend Coverage Ratio of JW Life Science was 2023 3.64 . It decreases by 56.29% higher compared to the previous year.

The JW Life Science Dividend Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Coverage
Date
Dividend Coverage
Jan 1, 2017
2.12 KRW
Jan 1, 2018
2.00 KRW
Jan 1, 2019
2.77 KRW
Jan 1, 2020
2.13 KRW
Jan 1, 2021
1.67 KRW
Jan 1, 2022
1.93 KRW
Jan 1, 2023
3.64 KRW
Jan 1, 2024
5.68 KRW
The JW Life Science Dividend Coverage history
YEARDividend CoverageYoY
5.68+56.29%
3.64+88.11%
1.93+15.86%
1.67-21.71%
2.13-23.12%
2.77+38.67%
2.00-5.73%
2.12-32.89%
3.16—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JW Life Science Stock analysis

What does JW Life Science do? JW Life Science Corp. manufactures intravenous fluids including basic IV fluids with water, electrolytes, and glucose, nutrient infusion solutions containing amino acids, lipids, proteins, vitamins, and minerals, and special infusion solutions for specific medical cases. The company produces total parenteral nutrition (TPN) products as part of its manufacturing focus. The primary buyers of these products are healthcare providers and hospitals requiring intravenous treatments for patient care. The company serves the medical sector by providing essential fluid and nutrition solutions for clinical use. The firm's product segments are defined by the types of IV fluids and TPN solutions they produce, targeting healthcare institutions that administer intravenous therapies. Basic IV fluids are used for general hydration and electrolyte balance, while nutrient infusion solutions support patient nutrition in critical care settings. Special infusion solutions address unique medical conditions requiring tailored treatments. The company's offerings are integral to hospital and clinic operations in delivering patient care. JW Life Science Corp. generates revenue through the sale of its manufactured intravenous fluid products to healthcare facilities. The company's business model relies on consistent demand for IV fluids and TPN solutions within the medical industry. Its products are distributed to hospitals and clinics that require these essential medical supplies for patient treatment protocols. JW Life Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JW Life Science stock

Dividend Coverage Ratio of JW Life Science is 5.68 in 2024.

Dividend Coverage Ratio of JW Life Science changed from 3.64 to 5.68, representing a 56.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio JW Life Science since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's JW Life Science historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — JW Life Science

All Key Metrics — JW Life Science